Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat
Go back to Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat(NASDAQ: ALBO) | Delayed: 44.15 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $44.15 | 52 Week High | $20.00 | |||
Open | $44.15 | 52 Week Low | $14.00 | |||
Day High | $44.15 | P/E | N/A | |||
Day Low | $44.15 | EPS | $0.00 | |||
Volume | 600 |